Table V.
Variable | Group A | Group B | Group C | F | P-value |
---|---|---|---|---|---|
TGF-β (ng/ml) | |||||
T1 | 2.34±0.51 | 2.21±0.36 | 2.36±0.58 | 1.37 | 0.26 |
T2 | 1.76±0.34 | 1.62±0.42 | 1.49±0.44a | 5.63 | <0.001 |
t | 6.69 | 7.54 | 8.45 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
IFNγ (ng/ml) | |||||
T1 | 130.33±6.82 | 131.13±5.12 | 128.92±4.19 | 2.08 | 0.12 |
T2 | 151.44±4.08 | 146.41±5.11a | 178.92±6.91a,b | 20.60 | <0.001 |
t | 18.78 | 14.94 | 43.75 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
IL-4 (ng/ml) | |||||
T1 | 34.92±6.78 | 35.43±6.11 | 34.96±5.78 | 0.10 | 0.90 |
T2 | 44.44±5.31 | 46.11±4.781 | 46.11±5.22a,b | 12.21 | <0.001 |
t | 5.35 | 6.09 | 10.12 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
IFNγ/IL-4 | |||||
T1 | 1.11±0.42 | 1.13±0.71 | 1.15±0.99 | 3.29 | 0.04 |
T2 | 2.78±0.48 | 2.86±0.32 | 2.91±0.33a | 1.91 | 0.15 |
t | 3.66 | 2.45 | 9.08 | ||
P-value | <0.001 | 0.01 | <0.001 |
P<0.05 vs. group A
P<0.05 vs. group B.